These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diffuse intraepidermal deposition of immunoreactants on direct immunofluorescence: a clue to the early diagnosis of epidermal necrolysis. King T; Helm TN; Valenzuela R; Bergfeld WF Int J Dermatol; 1994 Sep; 33(9):634-6. PubMed ID: 8002159 [TBL] [Abstract][Full Text] [Related]
6. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
7. Clues to pathogenesis of toxic epidermal necrolysis. Merot Y; Saurat JH Int J Dermatol; 1985 Apr; 24(3):165-8. PubMed ID: 3888879 [No Abstract] [Full Text] [Related]
8. Toxic epidermal necrolysis following chlorpromazine ingestion complicated by SIADH. Purcell P; Valmana A Postgrad Med J; 1996 Mar; 72(845):186. PubMed ID: 8731716 [No Abstract] [Full Text] [Related]
9. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523 [TBL] [Abstract][Full Text] [Related]
10. Stevens-Johnson syndrome and toxic epidermal necrolysis. Eginli A; Shah K; Watkins C; Krishnaswamy G Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080 [No Abstract] [Full Text] [Related]
15. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report. Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493 [TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica. East-Innis AD; Thompson DS West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894 [TBL] [Abstract][Full Text] [Related]
17. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034 [TBL] [Abstract][Full Text] [Related]
18. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867 [TBL] [Abstract][Full Text] [Related]
19. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)]. Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218 [TBL] [Abstract][Full Text] [Related]
20. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]